Pharmanutra S.p.A. (BIT:PHN)

Market Cap	484.96M
Revenue (ttm)	116.15M
Net Income (ttm)	16.61M
Shares Out	9.60M
EPS (ttm)	1.73
PE Ratio	29.22
Forward PE	22.78
Dividend	1.00 (1.98%)
Ex-Dividend Date	May 5, 2025

Volume	2,241
Average Volume	8,425
Open	51.40
Previous Close	50.50
Day's Range	50.50 - 51.40
52-Week Range	44.85 - 61.20
Beta	0.32
RSI	50.39
Earnings Date	Sep 8, 2025

About Pharmanutra

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. The company produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It also sells machinery and instruments for measuring body bioimp...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2003
• Employees: 118
• Stock Exchange: Borsa Italiana
• Ticker Symbol: PHN

Financial Performance

In 2024, Pharmanutra's revenue was 116.15 million, an increase of 15.33% compared to the previous year's 100.71 million. Earnings were 16.61 million, an increase of 29.43%.